Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Conditions: Respiratory Tract Diseases; Neoplasms; Neoplasms by Histologic Type; Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell; Tumor Virus Infections; Infections; Virus Diseases; DNA Virus Infections; Pathologic Processes; Disease Attributes; Recurrence; Papilloma; Respiratory Tract Infections; Papillomavirus Infections Intervention: Drug: Bevacizumab Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Epithelial Cancer | Papillomatosis | Research | Respiratory Medicine